nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel marker of lung-cancer risk in people with HIV
|
Makinson, Alain |
|
2017 |
4 |
2 |
p. e53-e55 nvt p. |
artikel |
2 |
Assessing progress with HIV incidence in national cohorts
|
Karim, Salim S Abdool |
|
2017 |
4 |
2 |
p. e56-e58 nvt p. |
artikel |
3 |
Assisted partner services for HIV case-finding
|
Hogben, Matthew |
|
2017 |
4 |
2 |
p. e55-e56 nvt p. |
artikel |
4 |
Assisted partner services for HIV in Kenya: a cluster randomised controlled trial
|
Cherutich, Peter |
|
2017 |
4 |
2 |
p. e74-e82 nvt p. |
artikel |
5 |
Commitment issues: PrEP adherence in injecting drug users
|
Page, Kimberly |
|
2017 |
4 |
2 |
p. e52-e53 nvt p. |
artikel |
6 |
Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study
|
Martin, Michael |
|
2017 |
4 |
2 |
p. e59-e66 nvt p. |
artikel |
7 |
Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study
|
Sigel, Keith |
|
2017 |
4 |
2 |
p. e67-e73 nvt p. |
artikel |
8 |
Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study
|
Justman, Jessica |
|
2017 |
4 |
2 |
p. e83-e92 nvt p. |
artikel |
9 |
The costs of inaction on PrEP
|
The Lancet HIV, |
|
2017 |
4 |
2 |
p. e51- 1 p. |
artikel |
10 |
The law and HIV
|
The Lancet HIV, |
|
2017 |
4 |
2 |
p. e51- 1 p. |
artikel |